CNS Pharmaceuticals News

Company Name Stock Ticker Symbol Market Type
CNS Pharmaceuticals Inc CNSP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0095 -3.66% 0.25 17:44:58
Open Price Low Price High Price Close Price Prev Close
0.2596 0.25 0.2596 0.2556 0.2595
more quote information »

Recent News

Date Time Source Heading
8/04/202217:03EDGARCurrent Report Filing (8-k)
7/28/202216:03EDGARCurrent Report Filing (8-k)
7/25/202208:05PRNUSCNS Pharmaceuticals Urges Shareholders to Vote in Favor of..
6/23/202208:35PRNUSCNS Pharmaceuticals Receives Approval from U.S. FDA for..
6/08/202208:35PRNUSCNS Pharmaceuticals Announces Presentation of Ongoing..
5/24/202207:00PRNUSCNS Pharmaceuticals Announces Presentation at the H.C...
5/18/202208:35PRNUSCNS Pharmaceuticals Announces Acceptance of Abstract for..
5/16/202216:56EDGARCurrent Report Filing (8-k)
5/16/202208:05PRNUSCNS Pharmaceuticals Reports First Quarter 2022 Financial..
5/13/202217:02EDGARQuarterly Report (10-q)
4/29/202217:37EDGARStatement of Changes in Beneficial Ownership (4)
4/28/202208:35PRNUSCNS Pharmaceuticals Receives Approval from Ethics Committee..
4/12/202208:35PRNUSCNS Pharmaceuticals to Participate in the Virtual Investor..
4/06/202209:49SEEKCNS Pharmaceuticals gets French regulatory nod for brain..
4/06/202208:35PRNUSCNS Pharmaceuticals Receives Approval from France Ethics..
4/05/202211:21SEEKCNS Pharmaceuticals stock soars 27% on Swiss regulatory nod..
4/05/202208:35PRNUSCNS Pharmaceuticals Receives Approval from Competent..
3/23/202208:35PRNUSCNS Pharmaceuticals to Participate in the 2022 Virtual..
3/14/202209:41EDGARStatement of Changes in Beneficial Ownership (4)
3/09/202214:35EDGARStatement of Changes in Beneficial Ownership (4)
3/09/202214:35EDGARStatement of Changes in Beneficial Ownership (4)
3/09/202209:20PRNUSCNS Pharmaceuticals Reiterates Operational Progress and..
3/08/202208:30EDGARStatement of Changes in Beneficial Ownership (4)
3/03/202208:50SEEKCNS Pharmaceuticals reports FY results
3/03/202208:41EDGARCurrent Report Filing (8-k)
3/03/202208:36EDGARAnnual Report (10-k)
3/03/202208:35PRNUSCNS Pharmaceuticals Reports Full Year 2021 Financial Results..
2/18/202217:05EDGARCurrent Report Filing (8-k)
2/01/202207:30GLOBEWPD Pharmaceuticals Secures Berubicin Sub-License Rights in..
2/01/202206:25EDGARNotice of Effectiveness (effect)
2/01/202206:15EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/20/202216:17EDGARSecurities Registration Statement (simplified Form) (s-3)
1/20/202208:45PRNUSCNS Pharmaceuticals to Present at the Virtual Investor 2022..
1/10/202217:00PRNUSCNS Pharmaceuticals Announces Closing of $11.5 Million..
1/10/202209:26EDGARCurrent Report Filing (8-k)
1/07/202208:05PRNUSCNS Pharmaceuticals to Present at the H.C. Wainwright..
1/06/202207:35SEEKCNS Pharmaceuticals to raise $11.5M in stock offering
1/06/202207:00PRNUSCNS Pharmaceuticals Announces $11.5 Million Private..
12/07/202108:30EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202109:10SEEKSwitzerland approves CNS Pharma's berubicin study in brain..
12/02/202108:35PRNUSCNS Pharmaceuticals Receives Approval from Switzerland..
11/22/202108:48EDGARStatement of Changes in Beneficial Ownership (4)
11/16/202108:00PRNUSCNS Pharmaceuticals to Present at the Virtual Investor..
10/11/202108:00GLOBECNS Pharmaceuticals Inc. Featured in Syndicated Broadcast..
9/30/202108:05PRNUSCNS Pharmaceuticals Doses First Group of Patients with..
Your Recent History
CNS Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220815 01:19:23